v3.26.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Allowance for credit loss $ 5 $ 10
Common stock, par value (in usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Shares issued (in shares) 158,842,224 158,747,196
Shares outstanding (in shares) 158,842,224 158,747,196
Accounts receivable, less allowances [1] $ 671 $ 645
Product loans receivable, current [2] 314 300
Accounts payable [3] 942 909
Accrued and other current liabilities [4] 468 467
Related Party    
Accounts receivable, less allowances 36 45
Product loans receivable, current 186 178
Accounts payable 7 2
Accrued and other current liabilities $ 73 $ 69
[1] Accounts receivable include related party receivables of $36 million and $45 million as of June 30, 2026 and December 31, 2025, respectively.
[2] Product loans receivable, current include related party loans receivables of $186 million and $178 million as of June 30, 2026 and December 31, 2025, respectively.
[3] Accounts payable include related party accounts payables of $7 million and $2 million as of June 30, 2026 and December 31, 2025, respectively.
[4] Accrued and other liabilities, current include related party payables of $73 million and $69 million as of June 30, 2026 and December 31, 2025, respectively.